ABSTRACT
In a test of adoptive cutaneous anaphylaxis, the influence of the phospholipase A2 inhibitor mepacrine, on the intensity of the local anaphylactic reaction was investigated in the skin of recipients following intracutaneous injection of syngenic immune splenocytes. Injection of the mepacrine solution with preincubated sensibilized splenocytes inhibits the cutaneous anaphylactic reaction after a single intravenous administration of allergen to recipients. The inoculation of immune splenocytes, preincubated in mepacrine but without the phospholipase A2 inhibitor, to the skin of syngeneic recipients is accompanied by less suppression of the local skin anaphylactic reaction than with a common injection of mepacrine with immune splenocytes.
Subject(s)
Passive Cutaneous Anaphylaxis/drug effects , Quinacrine/pharmacology , Animals , Dose-Response Relationship, Drug , Immunoglobulin E/biosynthesis , Injections, Intradermal , Male , Pollen/immunology , Rats , Rats, Inbred F344 , Spleen/immunologyABSTRACT
In a study of 95 practically healthy humans and in experiments on 148 animals (dogs, rabbits, rats), an attempt was made at assessing seasonal effects on immunological reactivity. The content of IgM antibody-forming cells was determined as well as the activity of blood and lymphoid NK and K cells and number of E rosette-forming peripheral blood lymphocytes. The most pronounced changes were observed in the specific immune response (IgM antibodies and K cells), which was enhanced during autumn and winter. Seasonal fluctuations in E rosette-forming cells and IgE antibodies were less extensive. The activity of NK cells was found to be relatively stable.